Evidence map›Paper›PMID 39531491›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Implantable 3D printed hydrogels with intrinsic channels for liver tissue engineering.

Tyler J Lieberthal, Tatevik Sahakyants, Naomi R Szabo-Wexler, Matthew J Hancock, Andrew P Spann, Mark S Oliver, Scott C Grindy, Craig M Neville, Joseph P Vacanti

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. A Systematic Review on Artificial Liver for Implantation.Journal of functional biomaterials · 2026
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tyler J Lieberthal3D BioLabs, Chadds Ford, PA 19317.ORCID 0000-0002-3250-8162
Tatevik Sahakyants3D BioLabs, Chadds Ford, PA 19317.ORCID 0000-0001-5868-8950
Naomi R Szabo-Wexler3D BioLabs, Chadds Ford, PA 19317.
Matthew J HancockVeryst Engineering, Needham, MA 02492.ORCID 0000-0001-9820-3620
Andrew P SpannVeryst Engineering, Needham, MA 02492.ORCID 0000-0002-5349-8514
Mark S OliverVeryst Engineering, Needham, MA 02492.
Scott C GrindyVeryst Engineering, Needham, MA 02492.ORCID 0000-0002-0947-7759
Craig M Neville3D BioLabs, Chadds Ford, PA 19317.ORCID 0000-0002-4363-5407
Joseph P VacantiDepartment of Surgery, Massachusetts General Hospital, Boston, MA 02114.

Funding

NSF ECCS-2025158
6 · The paper itself

Abstract

This study presents the design, fabrication, and evaluation of a general platform for the creation of three-dimensional printed devices (3DPDs) for tissue engineering applications. As a demonstration, we modeled the liver with 3DPDs consisting of a pair of parallel millifluidic channels that function as portal-venous (PV) and hepatobiliary (HB) structures. Perfusion of medium or whole blood through the PV channel supports the hepatocyte-containing HB channel. Device computer-aided design was optimized for structural stability, after which 3DPDs were 3D printed in a polyethylene(glycol) diacrylate photoink by digital light processing and evaluated in vitro. The HB channels were subsequently seeded with hepatic cells suspended in a collagen hydrogel. Perfusion of 3DPDs in bioreactors enhanced the viability and function of rat hepatoma cells and were maintained over time, along with improved liver-specific functions. Similar results were observed with primary rat hepatocytes, including significant upregulation of cytochrome p450 activity. Additionally, coculture experiments involving primary rat hepatocytes, endothelial cells, and mesenchymal stem cells in 3DPDs showed enhanced viability, broad liver-specific gene expression, and histological features indicative of liver tissue architecture. In vivo implantation of 3DPDs in a rat renal shunt model demonstrated successful blood flow through the devices without clot formation and maintenance of cell viability. 3D printed designs can be scaled in 3D space, allowing for larger devices with increased cell mass. Overall, these findings highlight the potential of 3DPDs for clinical translation in hepatic support applications.

Indexed as

HepatocytesHydrogelsLiverPrinting, Three-DimensionalTissue EngineeringAnimalsMesenchymal Stem CellsRatsTissue ScaffoldsHydrogels3D printinganastomosishydrogellivertissue engineering

Identifiers

PMID39531491
PMCPMC11588097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.